Veyong Pharma Attendi ad 22 CPHI Sinis MMXXIV

A Iunii XIX ad XXI, 22 CPHI Sinis et 17 PMEC Sinis erant tenuit ad novum Internationalis EXPO Centerin Shanghai. Li Jianjie, Generalis Procurator ofVeyongPharma, A subsidiary de Limin pharmaceuticals, Dr. Li Linhu, Deputy Director of R & D centro de LIMIN pharmaceuticals, Dr. Si Zhenjun, Director of Biological R & D Laboratory, Nie Fengqiu, Dr. Dr. Dr. Dr. Laboratory, Dr. Dr. Dr. Laboratory, Dr. Dr. Laboratory Dr. & D D Landoring, Dr. Dr. Laboratorium Dr. Dr. Dr. Laboratorium, Dr. Dr. Laboratory, Dr. Dr. Dr. Laboratorium, Dr. Dr. Laboratorium, NIGGRATOR PRINCERTOR CENTREGUS CENTRATOR, NIGGRATORIUS CENTROR CENTRORVeyongPharma et Chen Lusheng, Director of logistics Management Department, Attendi in se ferre cum international ipsum dolor.

In umbraculum E2A20:VeyongPharma ostendiivermectin, abamectin, tiamulin fumarate, Eprinomectinet alia products adcustomerscircum orbem terrarum. In comitatu scriptor ducens products transierunt US FDA et EU CEP certificaciones et intravit in international summus finem forum. Eius perfectus matrix layout, reliable uber qualis et dives productum varietate sunt plena exhibitors.

Et exhibitionem site est frequens cum populo. Internationalis ipsum quadrigis in plena adductius, habebat in-profundum commutationibus cum visitatores qui venit ad consulam, audiebat diligenter ut mos necessitatibus, et professionalem responsa, showing de comprehensive notam vires et cooperante valoremVeyongad global foro et statutum extensive hospites cum potentia customers in site.

Hoc se ferre has broadenedVeyongPharma scriptor Sales channels in internationalis foro et adhuc consolidated societatis scriptor fama et influentiam in internationalis API foro. In futuro, in comitatu et permanere accelerate in pace de International foro progressionem et adhuc augendaeVeyongPharma scriptor Brand Influence et Market aemulationes in agro Apiset apparatus.